United States Medical Instruments & Supplies news

20:07 11 Aug 2026

Seeking Alpha Earnings Main company 🇺🇸 United States

AngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth Conference - Slideshow

AngioDynamics, Inc. (ANGO) presented a slideshow at Canaccord Genuity's 46th Annual Growth Conference. The article, authored by SA Transcripts, highlights the company's participation in this event. SA Transcripts is responsible for publishing thousands of quarterly earnings call transcripts and other transcript-related projects on Seeking …

ANGO main company

Sharemaestro market context Trend signal active 52 weeks +78.9%

19:21 11 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus

Rocket Pharmaceuticals RCKT reported earnings of $1.08 per share (including certain one-time items) in the second quarter of 2026 in contrast to a loss of 62 cents per share incurred in the year-ago quarter. The Zacks Consensus Estimate for the company's bottom line was …

RGEN mentioned

Sharemaestro market context Trend signal started 52 weeks +31.8%

19:16 11 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues

Axsome Therapeutics AXSM incurred a loss of 99 cents per share in the second quarter of 2026, which was in line with the Zacks Consensus Estimate. The company had reported a loss of 97 cents per share in the year-ago quarter. Axsome's total revenues …

RGEN mentioned

Sharemaestro market context Trend signal started 52 weeks +31.8%

19:11 11 Aug 2026

TradingView Earnings Main company 🇺🇸 United States

Microbot Medical Inc. Q2 2026: Revenue $241K, Net loss $5.63M — 10-Q Summary

Microbot Medical Inc. reported its Q2 2026 results, announcing its first commercial revenue of $241,000, a significant increase from zero in the previous year. Despite this, the company posted a net loss of $5.63 million, worsening from a $3.5 million loss in the prior-year …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

19:10 11 Aug 2026

scanx.trade Earnings Main company 🇺🇸 United States

Microbot Medical Q2 Results: Sales miss by 29%, EPS in line

Microbot Medical (NASDAQ: MBOT) reported Q2 EPS of $(0.08), meeting analyst estimates and showing a 20% improvement year-over-year. However, the company's sales of $241,000 significantly missed the estimated $340,000 by 29.12%, raising concerns about its top-line growth despite improved per-share losses. This discrepancy suggests …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

18:48 11 Aug 2026

seekingalpha.com Earnings Main company 🇺🇸 United States

Harvard Bioscience targets 3% to 5% full-year 2026 revenue growth as CMT and China mix shifts gross margin to 57% to 59%

Earnings Call Insights: Harvard Bioscience (HBIO) Q2 2026 MANAGEMENT VIEW * "That disciplined focus and execution helped us deliver strong second quarter performance, highlighted by double-digit revenue growth across our CMT and preclinical portfolios and solid operational execution that reinforced our confidence in raising …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup negative 40.6%

18:46 11 Aug 2026

Wisner Baum Regulatory and legal Main company 🇺🇸 United States

AngioDynamics Port Catheter Lawsuit

Wisner Baum is actively investigating claims against AngioDynamics and Navilyst Medical concerning implantable port catheters due to reported complications like infection, thrombosis, device fracture, and migration. The AngioDynamics Port Catheter MDL, centralized in California, has grown to over 400 pending actions as of July …

ANGO main company

Sharemaestro market context Trend signal active 52 weeks +78.9%

18:43 11 Aug 2026

Morningstar Earnings Main company 🇺🇸 United States

New Launches and Pipeline Investments Support Alcon's Market Leadership and Strong Fundamentals

Alcon, a leading vision care company, is strengthening its market position through new product launches and strategic pipeline investments. The company operates in two key segments: vision care and surgical. Recent performance indicates that innovations, particularly in its Unity products, are driving growth despite …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

18:19 11 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …

AVTR mentioned

Sharemaestro market context Trend signal active 52 weeks +5.1%

18:14 11 Aug 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against Embecta Corp. (EMBC), urging investors who suffered losses to come forward. The lawsuit alleges that Embecta made misleading statements between November 25, 2025, and May 4, 2026, regarding its …

EMBC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.4% · Next-week setup negative 44.0%

17:23 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists

Inogen, Inc. INGN lowered its 2026 revenue outlook after second-quarter results showed continued U.S. channel pressure despite better profitability and international growth. The revision puts more focus on how quickly the company can adapt its commercial model. The key question is whether weaker direct …

RMD mentioned

Sharemaestro market context Price below Trend Line 52 weeks -25.0%

17:22 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Should Investors Buy Inogen as Low Valuation Meets Execution Risk?

Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based. Investors must weigh better cost control, expanding respiratory offerings and …

RMD mentioned

Sharemaestro market context Price below Trend Line 52 weeks -25.0%

17:21 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Cardinal Health, Inc. CAH reported fourth-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.91, beating the Zacks Consensus Estimate by 20.3%. The bottom line improved 40% year over year, aided by higher operating earnings, IEEPA tariff refunds, a lower tax rate and a …

WST mentioned COO mentioned

Sharemaestro market context Trend signal active 52 weeks +44.2%

16:41 11 Aug 2026

TradingView Earnings Main company 🇺🇸 United States

Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target

Alcon (ALC) raised its 2026 profitability outlook, leading to a 4% jump in its stock. The company now expects higher core operating-margin expansion and diluted EPS growth, driven by strong Q2 sales in Surgical and Vision Care, particularly a 26% surge in equipment sales …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

16:41 11 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

BTIG reiterates Buy on Alcon stock after Q2 results beat margins

BTIG reiterated a Buy rating and an $82.00 price target on Alcon Inc. after the company's strong second-quarter fiscal 2026 results, which saw approximately 7% growth excluding foreign exchange effects and core earnings per share of $0.84, beating expectations for gross and operating margins. …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

16:20 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RadNet, Inc. RDNT reported second-quarter 2026 adjusted earnings of 29 cents per share, down 14.7% year over year but ahead of the Zacks Consensus Estimate of 18 cents by 61.1%. GAAP EPS was 10 cents compared with 19 cents in the prior-year period. Growth …

WST mentioned COO mentioned

Sharemaestro market context Trend signal active 52 weeks +44.2%

16:15 11 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Zacks.com featured highlights include Envista, Sanmina, TAL Education and Avient

Zacks.com highlights four "PEG-Driven Value Stocks" for strong returns: Envista Corp. (NVST), Sanmina Corp. (SANM), TAL Education Group (TAL), and Avient Corp. (AVNT). The article explains the PEG ratio as a better indicator for value investing than P/E alone, helping investors identify stocks with …

NVST main company

Sharemaestro market context Price above Trend Line 52 weeks +36.4%

16:12 11 Aug 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop

A class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and its executives for securities fraud. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product category, leading to a 57% stock drop after disappointing Q2 …

EMBC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.4% · Next-week setup negative 44.0%

16:12 11 Aug 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox Encourages Investors of Embecta Corp. (NASDAQ: EMBC) to Contact the Firm Before Lead Plaintiff Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit follows a significant drop in Embecta's stock price after the company …

EMBC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.4% · Next-week setup negative 44.0%

16:10 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

Microbot Medical (NASDAQ:MBOT) announced its earnings results, reporting a quarterly loss of $0.08 per share, which met analyst expectations, but revenue of $0.24 million fell short of the $0.33 million consensus. Following the announcement, shares declined 13.4% to $1.68, nearing the company's one-year low. …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

16:10 11 Aug 2026

Bitget Analyst action Main company 🇺🇸 United States

Microbot Medical partners with Lovell Government Services to target federal healthcare systems

Microbot Medical has partnered with Lovell Government Services to expand its reach into federal healthcare systems, gaining access to over 2,000 facilities for its LIBERTY endovascular robotic system. Concurrently, Microbot signed an agreement with Sanmina to establish a second manufacturing site, anticipating increased demand. …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

16:07 11 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Becton, Dickinson and Company (BDX) Stock forecasts

This article provides a stock forecast for

BDX main company

Sharemaestro market context Price above Trend Line 52 weeks +17.6% · Next-week setup negative 32.1%

15:54 11 Aug 2026

https://hrtoday.in/ Market update Main company 🇺🇸 United States

Deepa Abi Joins Baxter International as Vice President, Global Business Solutions

Deepa Abi has been appointed as Vice President, Global Business Solutions at Baxter International Inc., bringing over 25 years of global leadership experience in healthcare, consumer goods, technology, and consulting. In her new role, she will lead the company's Global Business Solutions function, focusing …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +14.9% · Next-week setup negative 42.6%

15:45 11 Aug 2026

Benzinga Earnings Main company 🇺🇸 United States

Chief Financial Officer At Stevanato Group Sells $84K Of Stock

Marco Lago Dal, the Chief Financial Officer at Stevanato Group (NYSE: STVN), recently sold 4,209 shares of the company's stock for a total transaction value of $84,558. This insider sell, reported in an SEC Form 4 filing, comes as Stevanato Group's shares were up …

STVN main company

Sharemaestro market context Trend signal active 52 weeks -10.1%

15:14 11 Aug 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

EMBC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Embecta Corp. Securities Lawsuit - Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert for investors of Embecta Corp. (NASDAQ: EMBC) who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal results, specifically its pen needle business, …

EMBC main company

Sharemaestro market context Price below Trend Line 52 weeks -66.4% · Next-week setup negative 44.0%

15:10 11 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

GIC Private Ltd sells $21m Medline Inc. (MDLN) shares

GIC Private Ltd, a significant owner and director of Medline Inc. (MDLN), sold 590,284 shares of Class A Common Stock for approximately $21 million on August 7, 2026. Following these transactions, GIC Private Ltd directly holds over 24 million shares and indirectly holds an …

MDLN main company

Sharemaestro market context Price below Trend Line 34 weeks -15.4% · Next-week setup negative 44.1%

15:10 11 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

Microbot Medical Inc. (MBOT) reported a Q2 loss of $0.08 per share, in line with the Zacks Consensus Estimate, but missed revenue expectations with $0.24 million against an anticipated $0.31 million. Despite underperforming the market year-to-date, the company holds a Zacks Rank #2 (Buy), …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

15:05 11 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q2 CY2026, but sales fell by 4.1% year on year to $898 million. On the other hand, the company's full-year revenue guidance …

XRAY main company

Sharemaestro market context Price above Trend Line 52 weeks -10.1%

14:56 11 Aug 2026

Pluang Earnings Main company 🇺🇸 United States

Intuitive Surgical stock drops 30% YTD but shows strong growth and recurring revenue in surgical robotics.

Intuitive Surgical's stock has declined over 30% year-to-date, but the company demonstrates strong underlying growth, with its da Vinci system fleet expanding and recurring revenue now forming 85% of total revenue. The new da Vinci 5 platform is expected to drive long-term growth, and …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

14:41 11 Aug 2026

TradingView Earnings Main company 🇺🇸 United States

Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs

Alcon (ALC) reported stronger-than-expected Q2 2026 core earnings and revenues, leading to a 3.2% rise in its stock price. The company saw growth across its Surgical and Vision Care segments, driven by new product launches and price increases, despite some challenges in the implantables …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

14:40 11 Aug 2026

seekingalpha.com Market update Provider-linked mention 🇺🇸 United States

These stocks have some of Wall Street’s lowest short interest

[short sale] abluecup Stocks including Apple, Alphabet, Exxon Mobil, and JPMorgan are among the companies with relatively low short interest, according to a screen of stocks with market capitalizations above $2B. The screen includes stocks with short interest between 1% and 2% of shares …

BLCO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +15.3%

14:10 11 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Microbot Medical (NASDAQ: MBOT) posts first LIBERTY sales with $67M in cash

Microbot Medical (NASDAQ: MBOT) has reported its first commercial revenue from the LIBERTY® Endovascular Robotic System, totaling $241,000 in Q2 2026 and $346,000 for the first half of 2026. Despite these initial sales, the company incurred a net loss of $5.6 million for the …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

14:10 11 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Microbot Medical's LIBERTY System Gets Marketing Clearance in Israel

Microbot Medical (NASDAQ: MBOT) reported over 100% revenue and customer growth in Q2 2026, driven by the successful Full Market Release of its LIBERTY endovascular robotic system. The company expanded its U.S. sales territories, partnered for access to federal healthcare facilities, and received marketing …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

14:09 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue …

ISRG mentioned

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

13:40 11 Aug 2026

MarketBeat Analyst action Main company 🇺🇸 United States

Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating from BTIG Research

BTIG Research has reaffirmed its "Buy" rating for Merit Medical Systems (NASDAQ:MMSI), setting a price target of $105, which suggests a 17% upside. The company recently surpassed earnings estimates with an EPS of $1.19 and saw its revenue increase by 9.5% year-over-year to $418.84 …

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +4.1%

13:11 11 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

Harvard Bioscience beats estimates, raises 2026 guidance

Harvard Bioscience Inc. (NASDAQ:HBIO) surpassed analyst expectations for its second-quarter 2026 results, reporting adjusted EPS of -$0.14 and revenue of $22.7 million, exceeding estimates. The company also raised its full-year 2026 revenue guidance to 3%-5% YoY growth, citing strong demand for its telemetry and …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup negative 40.6%